AstraZeneca PLC (NASDAQ:AZN)
| 49.44 Delayed Data As of 3:59pm ET |  -0.50 / -1.00%Today’s Change | 45.39 Today|||52-Week Range 64.94 | -1.10% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 49.94 |
| Today’s open | 49.85 |
| Day’s range | 49.37 - 49.89 |
| Volume | 821,040 |
| Average volume (3 months) | 11,609,488 |
| Market cap | $131.1B |
Data as of 3:59pm ET, 04/12/2021
Growth & Valuation
| Earnings growth (last year) | +138.26% |
| Earnings growth (this year) | +27.12% |
| Earnings growth (next 5 years) | +16.90% |
| Revenue growth (last year) | +13.57% |
| P/E ratio | 40.5 |
| Price/Sales | 4.72 |
| Price/Book | 8.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | -0.51 | -1.00% |
| NVONovo Nordisk | -0.66 | -0.94% |
| BMYBristol-Myers Squibb | +0.10 | +0.16% |
| GSKGlaxoSmithKline | -0.58 | -1.58% |
Data as of 4:00pm ET, 04/12/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $0.65 |
| Annual revenue (last year) | $27.8B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 11.58% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
